EP 3813822 A2 20210505 - SOLID ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING TERIFLUNOMIDE
Title (en)
SOLID ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING TERIFLUNOMIDE
Title (de)
FESTE ORALE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT TERIFLUNOMID
Title (fr)
COMPOSITIONS PHARMACEUTIQUES SOLIDES D'ADMINISTRATION PAR VOIE ORALE COMPRENANT DU TÉRIFLUNOMIDE
Publication
Application
Priority
- TR 201809045 A 20180627
- TR 2019050497 W 20190624
Abstract (en)
[origin: WO2020005189A2] The present invention relates to pharmaceutical compositions comprising teriflunomide and one or more pharmaceutically acceptable excipient and are used in the treatment of autoimmune diseases such as especially systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis.
IPC 8 full level
A61K 31/277 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 47/10 (2017.01)
CPC (source: EP)
A61K 9/2018 (2013.01); A61K 9/2059 (2013.01); A61K 31/277 (2013.01); A61P 25/28 (2017.12)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020005189 A2 20200102; WO 2020005189 A3 20200312; EP 3813822 A2 20210505; EP 3813822 A4 20220316
DOCDB simple family (application)
TR 2019050497 W 20190624; EP 19824639 A 20190624